• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes.家族性帕金森病:对具有不同临床病理结果的相模原 PARK8(I2020T)原始家系的研究。
Parkinsonism Relat Disord. 2009 May;15(4):300-6. doi: 10.1016/j.parkreldis.2008.07.010. Epub 2008 Sep 18.
2
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.一种LRRK2突变作为原PARK8家族帕金森症的病因。
Ann Neurol. 2005 Jun;57(6):918-21. doi: 10.1002/ana.20484.
3
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.编码富含亮氨酸重复激酶2(dardarin,PARK8)的基因发生突变会导致家族性帕金森病:临床、病理、嗅觉及功能影像学和遗传学数据。
Brain. 2005 Dec;128(Pt 12):2786-96. doi: 10.1093/brain/awh667. Epub 2005 Nov 4.
4
PARK8 LRRK2 parkinsonism.PARK8型富亮氨酸重复激酶2相关性帕金森病
Curr Neurol Neurosci Rep. 2006 Jul;6(4):287-94. doi: 10.1007/s11910-006-0020-0.
5
[Clinical molecular genetics for PARK8 (LRRK2)].PARK8(LRRK2)的临床分子遗传学
Brain Nerve. 2007 Aug;59(8):839-50.
6
Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families.日本和德国帕金森病家族中富含亮氨酸重复激酶2基因激酶结构域I2020T突变的独立发生情况。
Neurosci Lett. 2007 Apr 24;417(1):21-3. doi: 10.1016/j.neulet.2007.02.086. Epub 2007 Mar 16.
7
A familial form of parkinsonism, dementia, and motor neuron disease: a longitudinal study.帕金森病、痴呆和运动神经元病的家族性形式:一项纵向研究。
Parkinsonism Relat Disord. 2014 Nov;20(11):1129-34. doi: 10.1016/j.parkreldis.2014.07.014. Epub 2014 Aug 19.
8
A family with Parkinsonism, essential tremor, restless legs syndrome, and depression.一个患有帕金森病、特发性震颤、不安腿综合征和抑郁症的家庭。
Neurology. 2011 May 10;76(19):1623-30. doi: 10.1212/WNL.0b013e318219fb42.
9
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.LRRK2基因的突变会导致具有多形性病理特征的常染色体显性帕金森病。
Neuron. 2004 Nov 18;44(4):601-7. doi: 10.1016/j.neuron.2004.11.005.
10
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.携带LRRK2基因突变的帕金森病患者的正电子发射断层扫描:与散发性帕金森病的比较及症状前代偿的证据
Brain. 2005 Dec;128(Pt 12):2777-85. doi: 10.1093/brain/awh607. Epub 2005 Aug 4.

引用本文的文献

1
Advancing precision medicine therapeutics for Parkinson's utilizing a shared quantitative systems pharmacology model and framework.利用共享的定量系统药理学模型和框架推进帕金森病的精准医学治疗。
Front Syst Biol. 2024 Mar 8;4:1351555. doi: 10.3389/fsysb.2024.1351555. eCollection 2024.
2
Neuropathological examination of 12 cases of familial Parkinson's disease with LRRK2 I2020T mutation including tau and TDP-43 pathology.对12例携带LRRK2 I2020T突变的家族性帕金森病患者进行神经病理学检查,包括tau蛋白和TDP - 43病理学检查。
J Neurol. 2025 Jun 9;272(7):450. doi: 10.1007/s00415-025-13148-3.
3
Widespread distribution of α-synuclein oligomers in LRRK2-related Parkinson's disease.α-突触核蛋白寡聚体在与富亮氨酸重复激酶2(LRRK2)相关的帕金森病中的广泛分布。
Acta Neuropathol. 2025 May 2;149(1):42. doi: 10.1007/s00401-025-02872-9.
4
Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases.路易体阴性的LRRK2突变病例中存在大量非包涵体型α-突触核蛋白病理改变。
Acta Neuropathol. 2025 May 2;149(1):41. doi: 10.1007/s00401-025-02871-w.
5
Updated MDSGene review on the clinical and genetic spectrum of LRRK2 variants in Parkinson´s disease.帕金森病中LRRK2变异体临床和基因谱的最新MDSGene综述。
NPJ Parkinsons Dis. 2025 Feb 17;11(1):30. doi: 10.1038/s41531-025-00881-9.
6
Widespread Distribution of α-Synuclein Oligomers in -related Parkinson's Disease.α-突触核蛋白寡聚体在帕金森病中的广泛分布
bioRxiv. 2024 Dec 20:2024.12.18.629265. doi: 10.1101/2024.12.18.629265.
7
Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials.多系统萎缩:生物标志物与临床试验的最新进展及新方向
J Neurol. 2024 May;271(5):2324-2344. doi: 10.1007/s00415-024-12269-5. Epub 2024 Mar 14.
8
Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2.在前脑α-突触核蛋白小鼠模型中模板化包涵体的形成与亮氨酸丰富重复激酶2(LRRK2)无关。
Neurobiol Dis. 2023 Nov;188. doi: 10.1016/j.nbd.2023.106338. Epub 2023 Oct 29.
9
Perspective on the current state of the LRRK2 field.对富含亮氨酸重复激酶2(LRRK2)领域当前状况的展望。
NPJ Parkinsons Dis. 2023 Jul 1;9(1):104. doi: 10.1038/s41531-023-00544-7.
10
Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson's Disease.LRRK2 基因突变在帕金森病中的作用概述。
Biomolecules. 2023 May 16;13(5):845. doi: 10.3390/biom13050845.

本文引用的文献

1
German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations.患有帕金森症、肌萎缩和痴呆症的德裔加拿大家庭(A家庭)——纵向观察
Parkinsonism Relat Disord. 1997 Nov;3(3):125-39. doi: 10.1016/s1353-8020(97)00013-8.
2
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.LRRK2相关帕金森病的表型、基因型及全球遗传外显率:一项病例对照研究。
Lancet Neurol. 2008 Jul;7(7):583-90. doi: 10.1016/S1474-4422(08)70117-0. Epub 2008 Jun 6.
3
Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation.LRRK2 突变导致帕金森病中的神经循环和黑质纹状体异常。
Neurology. 2007 Oct 16;69(16):1580-4. doi: 10.1212/01.wnl.0000268696.57912.64. Epub 2007 Jul 11.
4
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies.导致无路易小体帕金森病的G2019S LRRK2突变。
J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):626-8. doi: 10.1136/jnnp.2006.107904. Epub 2007 Jan 8.
5
Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions.伴有泛素免疫反应性神经元包涵体的额颞叶痴呆中的亮氨酸重复激酶2(Lrrk2)G2019S替代突变
Acta Neuropathol. 2007 May;113(5):601-6. doi: 10.1007/s00401-006-0178-1. Epub 2006 Dec 7.
6
Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation.与LRRK2基因Ile1371Val突变相关的帕金森病神经病理学
Mov Disord. 2007 Jan 15;22(2):275-8. doi: 10.1002/mds.21281.
7
Parkinsonism, Lrrk2 G2019S, and tau neuropathology.帕金森综合征、亮氨酸重复激酶2基因G2019S突变与tau蛋白神经病理学
Neurology. 2006 Oct 24;67(8):1506-8. doi: 10.1212/01.wnl.0000240220.33950.0c.
8
Biochemical and pathological characterization of Lrrk2.富含亮氨酸重复激酶2(Lrrk2)的生化与病理特征
Ann Neurol. 2006 Feb;59(2):315-22. doi: 10.1002/ana.20791.
9
Lrrk2 and Lewy body disease.富含亮氨酸重复激酶2与路易体病
Ann Neurol. 2006 Feb;59(2):388-93. doi: 10.1002/ana.20731.
10
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.携带LRRK2基因突变的帕金森病患者的正电子发射断层扫描:与散发性帕金森病的比较及症状前代偿的证据
Brain. 2005 Dec;128(Pt 12):2777-85. doi: 10.1093/brain/awh607. Epub 2005 Aug 4.

家族性帕金森病:对具有不同临床病理结果的相模原 PARK8(I2020T)原始家系的研究。

Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes.

作者信息

Hasegawa Kazuko, Stoessl A Jon, Yokoyama Teruo, Kowa Hisayuki, Wszolek Zbigniew K, Yagishita Saburo

机构信息

Division of Neurology, National Hospital Organization, Sagamihara National Hospital, Japan.

出版信息

Parkinsonism Relat Disord. 2009 May;15(4):300-6. doi: 10.1016/j.parkreldis.2008.07.010. Epub 2008 Sep 18.

DOI:10.1016/j.parkreldis.2008.07.010
PMID:18804399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2702757/
Abstract

BACKGROUND

Since the causative gene linked to PARK8 parkinsonism was identified as LRRK2, LRRK2 gene mutations have been found to occur in about 4% of patients with hereditary Parkinson disease (PD); this percentage is even higher in certain populations. Moreover, no clear clinical differences between PARK8-linked parkinsonism and sporadic PD have been identified. Neuropathologic findings have been diverse in PARK8 parkinsonism, but few of the clinicopathologic examinations have been performed in the same family tree. We aimed to describe PET and neuropathologic findings in members of the same family tree with PARK8 parkinsonism.

METHODS

We conducted PET of 2 subjects and neuropathologically examined 8 subjects in the same family from the Sagamihara district, the original source of PARK8-linked parkinsonism (I2020T mutation).

RESULTS

The results of the PET scans were virtually identical to those seen in sporadic PD. The neuropathologic study results showed pure nigral degeneration with no Lewy bodies in 6 cases. One case, however, showed the presence of Lewy bodies and was similar neuropathologically to conventional PD with Lewy bodies. Another case had multiple system atrophy pathology.

CONCLUSIONS

Our study of PARK8-linked parkinsonism affecting several members of the same pedigree shows that the same gene mutation can induce diverse neuropathologies, even if the clinical picture and PET findings are virtually identical.

摘要

背景

自从与PARK8型帕金森症相关的致病基因被确定为LRRK2以来,已发现LRRK2基因突变在约4%的遗传性帕金森病(PD)患者中出现;在某些人群中这一比例甚至更高。此外,尚未发现PARK8型帕金森症与散发性PD之间存在明显的临床差异。PARK8型帕金森症的神经病理学表现多样,但在同一谱系中进行的临床病理检查很少。我们旨在描述患有PARK8型帕金森症的同一谱系成员的PET和神经病理学表现。

方法

我们对来自相模原地区(PARK8型帕金森症的最初来源地,I2020T突变)的同一家庭中的2名受试者进行了PET检查,并对8名受试者进行了神经病理学检查。

结果

PET扫描结果与散发性PD的结果几乎相同。神经病理学研究结果显示,6例为单纯黑质变性,无路易小体。然而,有1例显示存在路易小体,神经病理学表现与传统的路易小体型PD相似。另一例有多系统萎缩病理改变。

结论

我们对影响同一谱系多名成员的PARK8型帕金森症的研究表明,即使临床表现和PET结果几乎相同,相同的基因突变也可诱发多种神经病理学改变。